AUTL stock · CTLT stock

AUTL vs CTLT

Autolus Therapeutics Ltd (AUTL) versus CTLT (CTLT) — a side-by-side from cached financials, not a winner call.

Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.

CTLT (CTLT) common stock.

Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.

CTLT does not have a complete income-statement cache yet.

AUTL currently screens at market cap $614.8M.

Not investment advice. Open the AUTL and CTLT stock pages for the full models.

Not investment advice.

Popular Stock Comparisons